ID   U2OS tGFP-ADCYAP1R1
AC   CVCL_B5WM
SY   ADCYAP1R1-tGFP_U2OS; PAC1-tGFP
DR   Innoprot; P30214
DR   Wikidata; Q112041875
CC   Population: Caucasian.
CC   Characteristics: Has been designed to assay potential agonists/antagonists against ADCYAP1R1, modulating its activation and the following redistribution process inside the cells (Innoprot=P30214).
CC   Characteristics: Transfected with ADCYAP1R1 N-terminally tagged with turboGFP.
CC   Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Transfected with: HGNC; 242; ADCYAP1R1.
CC   Transfected with: UniProtKB; Q6WV12; Pontellina plumata GFP2 (with p.Lys5Glu, p.Val117Met, p.Val149Asp, p.Val151Asp, p.Ala155Thr, p.Phe168Ser and p.Leu200Asp = TurboGFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 6
//